AIG
ACOR

American International Group’s Acorda Therapeutics ACOR Stock Holding History

American International Group’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-260
Closed -$29K – 3192
2020
Q1 		$29K Sell
260
-13
-5% -$2.56K ﹤0.01% 2857
2019
Q4 		$67K Sell
273
-7
-3% -$1.77K ﹤0.01% 2809
2019
Q3 		$97K Buy
280
+4
+1% +$2.17K ﹤0.01% 2630
2019
Q2 		$254K Buy
276
+3
+1% +$3.69K ﹤0.01% 2083
2019
Q1 		$435K Sell
273
-5
-2% -$9.01K ﹤0.01% 1799
2018
Q4 		$519K Sell
278
-3
-1% -$6.53K ﹤0.01% 1654
2018
Q3 		$663K Sell
281
-2
-0.7% -$6.19K ﹤0.01% 1705
2018
Q2 		$976K Buy
283
+52
+23% +$159K ﹤0.01% 1403
2018
Q1 		$655K Sell
231
-60
-21% -$180K ﹤0.01% 1528
2017
Q4 		$748K Buy
291
+2
+0.7% +$5.69K ﹤0.01% 1542
2017
Q3 		$821K Buy
289
+15
+5% +$39.5K ﹤0.01% 1463
2017
Q2 		$648K Buy
274
+53
+24% +$105K ﹤0.01% 1530
2017
Q1 		$556K Sell
221
-46
-17% -$132K ﹤0.01% 1533
2016
Q4 		$602K Sell
267
-4
-1% -$9.51K ﹤0.01% 1532
2016
Q3 		$679K Hold
271
– – ﹤0.01% 1434
2016
Q2 		$829K Sell
271
-3
-1% -$9.76K ﹤0.01% 1300
2016
Q1 		$869K Buy
274
+11
+4% +$45.7K ﹤0.01% 1586
2015
Q4 		$1.35M Buy
263
+7
+3% +$30.6K 0.01% 1306
2015
Q3 		$813K Buy
256
+2
+0.8% +$7.76K ﹤0.01% 1610
2015
Q2 		$1.02M Sell
254
-9
-3% -$34.8K ﹤0.01% 1566
2015
Q1 		$1.05M Buy
263
+2
+0.8% +$9.16K ﹤0.01% 1566
2014
Q4 		$1.28M Sell
261
-7
-3% -$30K 0.01% 1390
2014
Q3 		$1.09M Buy
268
+1
+0.4% +$3.75K ﹤0.01% 1509
2014
Q2 		$1.08M Hold
267
– – ﹤0.01% 1529
2014
Q1 		$1.21M Buy
267
+7
+3% +$28.3K 0.01% 1388
2013
Q4 		$909K Buy
260
+2
+0.8% +$7.8K ﹤0.01% 1539
2013
Q3 		$1.06M Sell
258
-3
-1% -$12.9K 0.01% 1369
2013
Q2 		$1.03M Buy
+261
New +$1.07M 0.01% 1361

Other funds holding ACOR

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

American International Group's ACOR Position: Q2 2020 in Review

American International Group sold out of Acorda Therapeutics (ACOR) in Q2 2020, closing a stake of 260 shares — an estimated $29K sold.

American International Group first reported a position in ACOR in Q2 2013 and held it in 28 quarters. The position peaked at $1.35M in Q4 2015. 79 funds tracked by Wall St. Rank hold ACOR as of Q2 2020.

  • American International Group reported no remaining Acorda Therapeutics position as of Q2 2020 after selling out during the quarter.
  • American International Group sold 260 Acorda Therapeutics shares in Q2 2020, an estimated $29K.
  • American International Group first reported a position in Acorda Therapeutics in Q2 2013 and held it in 28 quarters.
  • American International Group's Acorda Therapeutics position peaked at $1.35M in Q4 2015.
  • 79 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q2 2020.

Based on American International Group's 13F filing for Q2 2020, filed 12 Aug 2020.